Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis
- Ross A. Soo
- , Byoung Chul Cho
- , Joo Hang Kim
- , Myung Ju Ahn
- , Ki Hyeong Lee
- , Anastasia Zimina
- , Sergey Orlov
- , Igor Bondarenko
- , Yun Gyoo Lee
- , Yueh Ni Lim
- , Sung Sook Lee
- , Kyung Hee Lee
- , Yong Kek Pang
- , Chin Heng Fong
- , Jin Hyoung Kang
- , Chun Sen Lim
- , Pongwut Danchaivijitr
- , Saadettin Kilickap
- , James Chih Hsin Yang
- , Cagatay Arslan
- National University Cancer Institute
- Yonsei University
- CHA University
- Samsung Medical Center, Sungkyunkwan university
- Chungbuk National University
- State Budgetary Healthcare Institution of Omsk Region
- Pavlov First State Medical University of St. Petersburg
- Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine
- Kangbuk Samsung Hospital
- Kementerian Kesihatan Malaysia
- Inje University
- Yeungnam University
- University of Malaya
- Hospital Pulau Pinang
- Hospital Sultan Ismail
- Mahidol University
- Istinye University
- National Taiwan University
- Izmir Ekonomi University
- Yuhan Corporation
- Trakya University
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations